000 01444 a2200421 4500
005 20250518070606.0
264 0 _c20200928
008 202009s 0 0 eng d
022 _a1462-0332
024 7 _a10.1093/rheumatology/kez518
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHamann, Philip D H
245 0 0 _aEarly response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA.
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_c07 2020
300 _a1709-1714 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xdiagnosis
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aRegistries
650 0 4 _aRemission Induction
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
650 0 4 _aTumor Necrosis Factor Inhibitors
_xtherapeutic use
700 1 _aPauling, John D
700 1 _aMcHugh, Neil
700 1 _aHyrich, Kimme
700 1 _aShaddick, Gavin
773 0 _tRheumatology (Oxford, England)
_gvol. 59
_gno. 7
_gp. 1709-1714
856 4 0 _uhttps://doi.org/10.1093/rheumatology/kez518
_zAvailable from publisher's website
999 _c30300661
_d30300661